Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baizhen Jieyu Granules is a traditional Chinese medicine (TCM) formulation developed for the treatment of menopausal insomnia. It is administered as granules and used in clinical settings, particularly in China. The formula likely contains a combination of herbal ingredients traditionally used to address symptoms such as sleep disturbances, mood changes, and other menopausal complaints. Its mechanism of action is presumed to involve modulation of neurotransmitter systems and improvement of sleep quality through multi-target effects typical for TCM compounds; however, specific molecular targets are not well characterized in the biomedical literature. Clinical trials have been conducted to evaluate its efficacy and safety in patients with menopause-related insomnia[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baizhen Jieyu Granules.